Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Avalon GloboCare ( (ALBT) ) has issued an announcement.
On April 15, 2026, Avalon GloboCare disclosed that it had received a notice from Nasdaq stating the company was no longer in compliance with the exchange’s $1.00 minimum bid price requirement, after its stock traded below that threshold for 30 consecutive business days between March 1 and April 14, 2026. The notice does not immediately affect trading, but Avalon now has until October 12, 2026, to lift its share price back above $1.00 for at least 10 straight sessions or risk delisting, and management signaled it may consider options such as a reverse stock split to preserve its Nasdaq listing, a step that could affect existing shareholders and the company’s capital markets profile.
If Avalon fails to regain compliance within the initial 180-day grace period, Nasdaq may grant an additional 180 days provided other listing criteria are met and the company commits to curing the deficiency. Should Avalon ultimately be unable to meet the bid price standard, its shares could be delisted from Nasdaq, although the company would still have the right to appeal, underscoring heightened listing-risk concerns for investors and potential pressure on management to take corrective corporate actions.
More about Avalon GloboCare
Avalon GloboCare Corp. is a healthcare-focused company whose shares trade on The Nasdaq Capital Market under the symbol ALBT. The company operates in the broader life sciences and medical sector, and its Nasdaq listing provides access to public equity markets and visibility among healthcare and biotech investors.
Average Trading Volume: 7,210,147
Technical Sentiment Signal: Sell
Current Market Cap: $3.18M
See more data about ALBT stock on TipRanks’ Stock Analysis page.